TAMAR HOWSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-11-12 Tamar Howson 50,000 *
2011-02-18 Tamar Howson 75,000 *
2012-11-19 Tamar Howson(2) 86,060 * (2) Includes options to purchase 48,000 shares of common stock, which are exercisable on November 1, 2012 or within 60 days thereafter.

Data sourced from SEC filings. Last updated: 2025-10-11